EPA and/or DHA? A test question on the principles and opportunities in utilizing the therapeutic potential of omega-3 fatty acids
- PMID: 27436589
- PMCID: PMC5003160
- DOI: 10.1194/jlr.C071084
EPA and/or DHA? A test question on the principles and opportunities in utilizing the therapeutic potential of omega-3 fatty acids
Similar articles
-
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.J Clin Lipidol. 2012 Jan-Feb;6(1):5-18. doi: 10.1016/j.jacl.2011.10.018. Epub 2011 Nov 3. J Clin Lipidol. 2012. PMID: 22264569 Review.
-
Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.J Nutr Biochem. 2015 Nov;26(11):1385-92. doi: 10.1016/j.jnutbio.2015.07.007. Epub 2015 Jul 26. J Nutr Biochem. 2015. PMID: 26320676
-
Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice.Lipids Health Dis. 2015 Jul 22;14:74. doi: 10.1186/s12944-015-0072-8. Lipids Health Dis. 2015. PMID: 26193881 Free PMC article.
-
The Omega-3 Fatty Acids EPA and DHA, as a Part of a Murine High-Fat Diet, Reduced Lipid Accumulation in Brown and White Adipose Tissues.Int J Mol Sci. 2019 Nov 24;20(23):5895. doi: 10.3390/ijms20235895. Int J Mol Sci. 2019. PMID: 31771283 Free PMC article.
-
Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.Am J Ther. 2016 May-Jun;23(3):e905-10. doi: 10.1097/MJT.0000000000000165. Am J Ther. 2016. PMID: 25828517 Review.
Cited by
-
Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?Int J Mol Sci. 2023 May 30;24(11):9520. doi: 10.3390/ijms24119520. Int J Mol Sci. 2023. PMID: 37298468 Free PMC article. Review.
-
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.Hypertension. 2020 Jul;76(1):3-15. doi: 10.1161/HYPERTENSIONAHA.120.13898. Epub 2020 Jun 1. Hypertension. 2020. PMID: 32475311 Free PMC article.
References
-
- Lavie C. J., Milani R. V., Mehra M. R., and Ventura H. O.. 2009. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J. Am. Coll. Cardiol. 54: 585–594. - PubMed
-
- Mozaffarian D., and Wu J. H.. 2011. Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58: 2047–2067. - PubMed
-
- Ameur A., Enroth S., Johansson A., Zaboli G., Igl W., Johansson A. C., Rivas M. A., Daly M. J., Schmitz G., Hicks A. A., et al. . 2012. Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids. Am. J. Hum. Genet. 90: 809–820. - PMC - PubMed
-
- Martinelli N., Girelli D., Malerba G., Guarini P., Illig T., Trabetti E., Sandri M., Friso S., Pizzolo F., Schaeffer L., et al. . 2008. Fads genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am. J. Clin. Nutr. 88: 941–949. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials